🇺🇸 FDA
Patent

US 10466249

Methods and reagents for analyzing protein-protein interfaces

granted A61PA61P37/06

Quick answer

US patent 10466249 (Methods and reagents for analyzing protein-protein interfaces) held by Revolution Medicines, Inc. expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Revolution Medicines, Inc.
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P37/06